Open official notice

Santen “Pranoprofen Ophthalmic Solution 0.1% ‘Santen’” - Recall

Official notice

19 Oct 2026

Last checked

27 Oct 2026

RecallScope risk estimate:MediumCAA Japan

An official CAA Japan notice concerns Santen “Pranoprofen Ophthalmic Solution 0.1% ‘Santen’” - Recall. The content of the active ingredient pranoprofen was found to have decreased and to fall below the approved specification within the shelf life. Reason for recall: Stability monitoring revealed a decrease in the content of the active ingredient pranoprofen in some lots of the affected product, and it was determined that the content would fall below the approved specification within the shelf life. An investigation confirmed that a particular raw material with a high iron ion content contributed to the degradation of pranoprofen in the ophthalmic solution. Therefore, lots manufactured using raw material with a high iron ion content whose pranoprofen content may fall below the approved specification are being voluntarily recalled. Specific potential health effects: Although the pranoprofen content in the recalled lots has decreased, the decrease is small, and the iron ion content is also at trace levels. Consequently, the company considers that there is no possibility of serious adverse health effects arising from this issue. To date, no reports of adverse health effects or lack of efficacy considered attributable to this issue have been received. Published 2026-10-19.

What to do now

The company has identified all pharmaceutical wholesalers and other recipients supplied with the affected lot numbers and will notify them of the recall in writing and collect the products.

Recall number

2-12999

Official notice

2026-10-19

The hazard

The content of the active ingredient pranoprofen was found to have decreased and to fall below the approved specification within the shelf life. Reason for recall: Stability monitoring revealed a decrease in the content of the active ingredient pranoprofen in some lots of the affected product, and it was determined that the content would fall below the approved specification within the shelf life. An investigation confirmed that a particular raw material with a high iron ion content contributed to the degradation of pranoprofen in the ophthalmic solution. Therefore, lots manufactured using raw material with a high iron ion content whose pranoprofen content may fall below the approved specification are being voluntarily recalled. Specific potential health effects: Although the pranoprofen content in the recalled lots has decreased, the decrease is small, and the iron ion content is also at trace levels. Consequently, the company considers that there is no possibility of serious adverse health effects arising from this issue. To date, no reports of adverse health effects or lack of efficacy considered attributable to this issue have been received.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

5mL×50本, PR4085, PR4091, PR4093, PR4094 5mL×10本, PR4086, PR4090, PR4092, PR4095

Recall Numbers

2-12999

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

プラノプロフェン点眼液0.1%「参天」

Hazard

The content of the active ingredient pranoprofen was found to have decreased and to fall below the approved specification within the shelf life. Reason for recall: Stability monitoring revealed a decrease in the content of the active ingredient pranoprofen in some lots of the affected product, and it was determined that the content would fall below the approved specification within the shelf life. An investigation confirmed that a particular raw material with a high iron ion content contributed to the degradation of pranoprofen in the ophthalmic solution. Therefore, lots manufactured using raw material with a high iron ion content whose pranoprofen content may fall below the approved specification are being voluntarily recalled. Specific potential health effects: Although the pranoprofen content in the recalled lots has decreased, the decrease is small, and the iron ion content is also at trace levels. Consequently, the company considers that there is no possibility of serious adverse health effects arising from this issue. To date, no reports of adverse health effects or lack of efficacy considered attributable to this issue have been received.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

参天製薬

Manufacturer

参天製薬株式会社

Phone

06-7664-8621

Brand: 参天製薬. Contact: 参天製薬株式会社 コールセンター. Phone 06-7664-8621.

Source & status

Source

Tier

official

Category

HEALTH

Official classification

PMDA Class II — 回収

Recall details

Recall number

2-12999

Event id

CAA-00000035997

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 19 Oct 2026. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button